First Light Asset Management, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), First Light Asset Management, LLC reported 44 stock positions worth $1.1 billion. Its top holding was Paragon 28 (FNA) at 4.9% of the portfolio, followed by Alphatec (ATEC, 4.9%) and Crinetics Pharmaceuticals (CRNX, 4.7%). Compared with Q1 2024, it opened 5 new positions, sold out of 11, added to 22 and reduced 16. The biggest buy was Livanova (LIVN, shares +591%) and the biggest sale an exit from Shockwave Medical (SWAV).
- Most Recent 13F
- Q2 2026
- Location
- Edina, MN
- CIK
- 0001600004
- Portfolio Value
- $1.1B (Q2 2024)
- SEC Filing
- 0001999371-24-010170 ↗ filed Aug 14, 2024
Holdings Value
Holdings 44 stocks · $1.1B
| FNA Paragon 28 Inc. | 4.90% | 8,174,832 | $55.9M | Add +115.0% |
| ATEC Alphatec Holdings Inc. | 4.88% | 5,327,978 | $55.7M | Reduce -1.7% |
| CRNX Crinetics Pharmaceuticals Inc. | 4.71% | 1,200,508 | $53.8M | Reduce -29.0% |
| NEO Neogenomics Inc. | 4.60% | 3,782,561 | $52.5M | Add +14.6% |
| XENE Xenon Pharmaceuticals Inc. | 4.46% | 1,306,260 | $50.9M | Reduce -1.1% |
| TMDX Transmedics Group Inc. | 3.97% | 300,600 | $45.3M | Reduce -57.8% |
| ATRC Atricure Inc. | 3.92% | 1,964,703 | $44.7M | Add +42.1% |
| PODD Insulet Corp. | 3.81% | 215,637 | $43.5M | Add +42.6% |
| CNTA Centessa Pharmaceuticals Ltd. | 3.78% | 4,780,560 | $43.2M | Add +59.2% |
| NTRA Natera Inc. | 3.50% | 369,068 | $40.0M | Reduce -43.8% |
| RARE Ultragenyx Pharmaceutical Inc. | 3.47% | 963,146 | $39.6M | Add +21.9% |
| LIVN Livanova PLC | 3.41% | 710,390 | $38.9M | Add +591.1% |
| INSM Insmed Inc. | 3.24% | 551,303 | $36.9M | Add +95.0% |
| PLRX Pliant Therapeutics Inc. | 3.21% | 3,401,213 | $36.6M | Reduce -3.8% |
| VERA Vera Therapeutics Inc. | 3.19% | 1,005,723 | $36.4M | Add +130.6% |
| SIBN Si-Bone Inc. | 2.80% | 2,473,289 | $32.0M | Add +0.0% |
| RCM R1 RCM Inc. | 2.71% | 2,464,809 | $31.0M | Reduce -3.4% |
| PHLT Performant Healthcare Inc. | 2.67% | 10,514,200 | $30.5M | Reduce -0.0% |
| OSCR Oscar Health Inc. Class A | 2.59% | 1,865,922 | $29.5M | Reduce -11.3% |
| TNDM Tandem Diabetes Care Inc. | 2.50% | 708,482 | $28.5M | Add +49.1% |
| BCYC Bicycle Therapeutics PLC-ADR | 2.46% | 1,384,768 | $28.0M | Add +16.1% |
| EVH Evolent Health Inc. Class A | 2.42% | 1,445,305 | $27.6M | Add +401.5% |
| HCAT Health Catalyst Inc. | 2.22% | 3,956,089 | $25.3M | Add +438.5% |
| AXGN Axogen Inc. | 2.12% | 3,344,033 | $24.2M | Add +336.6% |
| GPCR Structure Therapeutics Inc. | 2.03% | 590,647 | $23.2M | Add +296.1% |
| NARI Inari Medical Inc. | 1.99% | 472,384 | $22.7M | Add +120.8% |
| ANAB Anaptysbio Inc. | 1.71% | 779,158 | $19.5M | Reduce -17.5% |
| OPRX Optimizerx Corp. | 1.60% | 1,826,961 | $18.3M | Add +5.1% |
| TCMD Tactile Systems Technology I | 1.40% | 1,338,902 | $16.0M | Reduce -49.3% |
| DYN Dyne Therapeutics Inc. | 1.18% | 382,433 | $13.5M | Add +261.0% |
| KRMD Koru Medical Systems Inc. | 1.17% | 5,038,387 | $13.4M | Reduce -3.5% |
| AVTR Avantor Inc. | 1.11% | 596,124 | $12.6M | Reduce -29.9% |
| GH Guardant Health Inc. | 1.06% | 416,967 | $12.0M | Add +119.7% |
| PCVX Vaxcyte Inc. | 0.92% | 139,729 | $10.6M | Add +131.8% |
| SVRA Savara Inc. | 0.71% | 2,002,219 | $8.1M | New |
| PEN Penumbra Inc. | 0.68% | 43,108 | $7.8M | Add +13.6% |
| HUM Humana Inc. | 0.53% | 16,139 | $6.0M | New |
| CNC Centene Corp. | 0.52% | 88,827 | $5.9M | New |
| EXAS Exact Sciences Corp. | 0.46% | 125,386 | $5.3M | New |
| STVN Stevanato Group SPA | 0.44% | 272,833 | $5.0M | Reduce -67.4% |
| ASND Ascendis Pharma A/S | 0.43% | 36,157 | $4.9M | New |
| INSP Inspire Medical Systems Inc. | 0.33% | 28,135 | $3.8M | Reduce -79.9% |
| SLP Simulations Plus Inc. | 0.12% | 28,259 | $1.4M | Reduce -1.7% |
| SONENDO INC | 0.03% | 5,143,615 | $350K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| SWAV Shockwave Medical Inc. | Sold out | 0.00% | −4.03 |
| IRTC Irhythm Holdings Inc. | Sold out | 0.00% | −3.74 |
| INSP Inspire Medical Systems Inc. | Reduce -79.9% | 0.33% | −1.97 |
| MODN Model N Inc. | Sold out | 0.00% | −1.95 |
| TCMD Tactile Systems Technology I | Reduce -49.3% | 1.40% | −1.89 |
| PRVA Privia Health Group Inc. | Sold out | 0.00% | −1.66 |
| SCTL Societal Cdmo Inc. | Sold out | 0.00% | −1.63 |
| STVN Stevanato Group SPA | Reduce -67.4% | 0.44% | −1.62 |
| ALPN Alpine Immune Sciences Inc. | Sold out | 0.00% | −1.52 |
| CRNX Crinetics Pharmaceuticals Inc. | Reduce -29.0% | 4.71% | −1.34 |
| TELA Tela Bio Inc. | Sold out | 0.00% | −1.20 |
| IDYA Ideaya Biosciences Inc. | Sold out | 0.00% | −1.13 |
| NTRA Natera Inc. | Reduce -43.8% | 3.50% | −1.10 |
| PRTA Prothena Corp. PLC | Sold out | 0.00% | −0.84 |
| ATEC Alphatec Holdings Inc. | Reduce -1.7% | 4.88% | −0.84 |
| PLRX Pliant Therapeutics Inc. | Reduce -3.8% | 3.21% | −0.83 |
| THC Tenet Healthcare Corp. | Sold out | 0.00% | −0.64 |
| AVTR Avantor Inc. | Reduce -29.9% | 1.11% | −0.56 |
| VTYX Ventyx Biosciences Inc. | Sold out | 0.00% | −0.26 |
| TMDX Transmedics Group Inc. | Reduce -57.8% | 3.97% | −0.06 |
| SLP Simulations Plus Inc. | Reduce -1.7% | 0.12% | +0.03 |
| ANAB Anaptysbio Inc. | Reduce -17.5% | 1.71% | +0.08 |
| XENE Xenon Pharmaceuticals Inc. | Reduce -1.1% | 4.46% | +0.11 |
| OSCR Oscar Health Inc. Class A | Reduce -11.3% | 2.59% | +0.19 |
| RCM R1 RCM Inc. | Reduce -3.4% | 2.71% | +0.20 |
| KRMD Koru Medical Systems Inc. | Reduce -3.5% | 1.17% | +0.23 |
| PHLT Performant Healthcare Inc. | Reduce -0.0% | 2.67% | +0.31 |
Portfolio Buys Q1 2024 → Q2 2024
| LIVN Livanova PLC | Add +591.1% | 3.41% | +2.97 |
| INSM Insmed Inc. | Add +95.0% | 3.24% | +2.65 |
| PODD Insulet Corp. | Add +42.6% | 3.81% | +1.83 |
| HCAT Health Catalyst Inc. | Add +438.5% | 2.22% | +1.79 |
| VERA Vera Therapeutics Inc. | Add +130.6% | 3.19% | +1.75 |
| EVH Evolent Health Inc. Class A | Add +401.5% | 2.42% | +1.70 |
| AXGN Axogen Inc. | Add +336.6% | 2.12% | +1.65 |
| GPCR Structure Therapeutics Inc. | Add +296.1% | 2.03% | +1.54 |
| FNA Paragon 28 Inc. | Add +115.0% | 4.90% | +1.31 |
| TNDM Tandem Diabetes Care Inc. | Add +49.1% | 2.50% | +1.21 |
| NARI Inari Medical Inc. | Add +120.8% | 1.99% | +1.21 |
| CNTA Centessa Pharmaceuticals Ltd. | Add +59.2% | 3.78% | +1.19 |
| DYN Dyne Therapeutics Inc. | Add +261.0% | 1.18% | +0.95 |
| GH Guardant Health Inc. | Add +119.7% | 1.06% | +0.76 |
| SVRA Savara Inc. | New | 0.71% | +0.71 |
| ATRC Atricure Inc. | Add +42.1% | 3.92% | +0.70 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +21.9% | 3.47% | +0.64 |
| NEO Neogenomics Inc. | Add +14.6% | 4.60% | +0.62 |
| PCVX Vaxcyte Inc. | Add +131.8% | 0.92% | +0.61 |
| HUM Humana Inc. | New | 0.53% | +0.53 |
| CNC Centene Corp. | New | 0.52% | +0.52 |
| EXAS Exact Sciences Corp. | New | 0.46% | +0.46 |
| ASND Ascendis Pharma A/S | New | 0.43% | +0.43 |
| BCYC Bicycle Therapeutics PLC-ADR | Add +16.1% | 2.46% | +0.18 |
| PEN Penumbra Inc. | Add +13.6% | 0.68% | +0.03 |
| OPRX Optimizerx Corp. | Add +5.1% | 1.60% | −0.01 |
| SIBN Si-Bone Inc. | Add +0.0% | 2.80% | −0.30 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 31 | $1.6B | NEO, SIBN, AXGN, APGE, PVLA |
| Q1 2026 | 35 | $1.1B | AXGN, PVLA, NEO, SIBN, CNTA |
| Q4 2025 | 33 | $1.3B | AXGN, NEO, SIBN, PVLA, CNTA |
| Q3 2025 | 41 | $1.1B | AXGN, PHLT, CNTA, NEO, AMLX |
| Q2 2025 | 38 | $771.3M | ANAB, CNTA, PHLT, NEO, AXGN |
| Q1 2025 | 37 | $875.7M | ANAB, AXGN, CNTA, NEO, TWST |
| Q4 2024 | 36 | $1.0B | FNA, CNTA, AXGN, ATRC, TWST |
| Q3 2024 | 38 | $1.2B | CNTA, FNA, EVH, AXGN, ATRC |
| Q2 2024 | 44 | $1.1B | FNA, ATEC, CRNX, NEO, XENE |
| Q1 2024 | 50 | $1.3B | CRNX, ATEC, NTRA, XENE, PLRX |